These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21831375)

  • 21. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
    Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
    Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E
    Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].
    Han YL; Deng J; Jing QM; Wang SL; Ma YY; Luan B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):483-6. PubMed ID: 16842659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Sen N; Afsar B; Ozcan F; Buyukkaya E; Isleyen A; Akcay AB; Yuzgecer H; Kurt M; Karakas MF; Basar N; Hajro E; Kanbay M
    Atherosclerosis; 2013 May; 228(1):203-10. PubMed ID: 23489347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction.
    Celik T; Kaya MG; Akpek M; Gunebakmaz O; Balta S; Sarli B; Duran M; Demirkol S; Uysal OK; Oguzhan A; Gibson CM
    Angiology; 2015 Feb; 66(2):155-62. PubMed ID: 24301422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients.
    Corrada E; Cappelleri A; Belli G; Genovese S; Barbaro C; Gasparini G; Pagnotta P; Rossi M; Zavalloni D; Presbitero P
    Minerva Cardioangiol; 2008 Oct; 56(5):445-52. PubMed ID: 18813179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Kaya MG; Uyarel H; Akpek M; Kalay N; Ergelen M; Ayhan E; Isik T; Cicek G; Elcik D; Sahin O; Cosgun SM; Oguzhan A; Eren M; Gibson CM
    Am J Cardiol; 2012 Feb; 109(4):486-91. PubMed ID: 22100027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
    Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
    Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.
    Ege M; Güray U; Güray Y; Yılmaz MB; Demirkan B; Saşmaz A; Korkmaz S
    Anadolu Kardiyol Derg; 2011 May; 11(3):213-7. PubMed ID: 21421510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil/Lymphocyte Ratio as a Predictor of In-Hospital Major Adverse Cardiac Events, New-Onset Atrial Fibrillation, and No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction.
    Wagdy S; Sobhy M; Loutfi M
    Clin Med Insights Cardiol; 2016; 10():19-22. PubMed ID: 26884687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired myocardial perfusion score and inflammatory markers in patients undergoing primary angioplasty for acute myocardial infarction.
    Exaire JE; Fathi RB; Brener SJ; Karha J; Ellis SG; Bhatt DL
    Arch Cardiol Mex; 2006; 76(4):376-82. PubMed ID: 17315613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris.
    Duygu H; Turkoglu C; Kirilmaz B; Turk U
    J Invasive Cardiol; 2008 Mar; 20(3):120-4. PubMed ID: 18316827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
    Celik T; Iyisoy A; Kursaklioglu H; Turhan H; Kilic S; Kose S; Amasyali B; Isik E
    Coron Artery Dis; 2005 Aug; 16(5):293-9. PubMed ID: 16000887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-year clinical outcomes of ST segment elevation myocardial infarction patients treated with emergent percutaneous coronary intervention: the impact of thrombus burden.
    Tungsubutra W; Towashiraporn K; Tresukosol D; Chotinaiwattrakul C; Phankingthongkum R; Wongpraparut N; Panchavinnin P
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S139-46. PubMed ID: 24772591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction.
    Hong YJ; Jeong MH; Choi YH; Ko JS; Lee MG; Kang WY; Lee SE; Kim SH; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Cardiol; 2009 Aug; 54(1):36-44. PubMed ID: 19632518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relation of admission neutrophil/lymphocyte ratio to angiographic no-reflow phenomenon in patients with ST-elevated myocardial infarction undergoing primary coronary intervention].
    Niu X; Zhang Y; He S; Chen D; Yan D; Yao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jul; 35(7):856-60. PubMed ID: 25294082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of mean platelet volume and pre- and postinterventional flow with infarct-related artery in ST-segment elevation myocardial infarction.
    Elbasan Z; Gür M; Sahin DY; Kuloglu O; Icen YK; Turkoglu C; Ozkan B; Uysal OK; Kalkan GY; Cayli M
    Angiology; 2013 Aug; 64(6):440-6. PubMed ID: 22887730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
    Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.